Fibrodysplasia ossificans progressiva (FOP) is a rare condition characterized by progressive heterotopic ossifications and congenital hallux valgus deformities. The common underlying genetic cause is an ACVR1 mutation, resulting in altered bone morphogenetic protein (BMP) regulation. Trauma and/or minor procedures aggravate the abnormal bony formation in soft tissues. This report presents a 3-year-old child with this condition who presented pseudo-ankylosis of the temporomandibular joint (TMJ) after minor craniofacial trauma. Abnormal ossification in the medial pterygoid muscle was identified as the causative abnormality for the presentation with trismus.
AkessonLSSavarirayanR. Fibrodysplasia Ossificans Progressiva. In: AdamMPEvermanDBMirzaaGM, et al., eds. GeneReviews®. University of Washington, Seattle; June 11, 2020.1‐19.
2.
PatinG. Lettres choisies de fev M, Guy Patin (Letter of Aug. 27, 1648). Cologne, Pierre du Laurens, 1692, vol. I, 28. 1648.
3.
GuzuMGaillotHARosatiMNicolierAHennetPR. Bilateral fibrodysplasia ossificans affecting the masticatory muscles and causing irreversible trismus in a domestic shorthair cat. JFMS Open Rep. 2019;5(1):2055116919839857.
4.
ShoreEMXuMFeldmanGJ, et al.A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006;38(5):525‐527.
5.
NakajimaMHagaNTakikawaKManabeNNishimuraGIkegawaS. The ACVR1 617G>A mutation is also recurrent in three Japanese patients with fibrodysplasia ossificans progressiva. J Hum Genet. 2007;52(5):473‐475.
6.
KaplanFSXuMSeemannP, et al.Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat. 2009;30(3):379‐390.
7.
KaplanFSMukaddamMABaujatG, et al.The medical management of fibrodysplasia ossificans progressiva: Current treatment considerations. Proc Intl Clin Council FOP. 2021;2:1‐127.
8.
LinGTChangHWLiuCSHuangPJWangHCChengYM. De novo 617G-A nucleotide mutation in the ACVR1 gene in a Taiwanese patient with fibrodysplasia ossificans progressiva. J Hum Genet. 2006;51(12):1083‐1086.
9.
BarruetEMoralesBMCainCJ, et al.NF-κB/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification. JCI Insight. 2018;3(22):e122958.
10.
KaplanFSAndolinaJRAdamsonPC, et al.Early clinical observations on the use of imatinib mesylate in FOP: a report of seven cases. Bone. 2018;109:276‐280.
LuchettiWCohenRBHahnGV, et al.Severe restriction in jaw movement after routine injection of local anesthetic in patients who have fibrodysplasia ossificans progressiva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81(1):21‐25.
13.
van der MeijEHBeckingAGvan der WaalI. Fibrodysplasia ossificans progressiva. An unusual cause of restricted mandibular movement. Oral Dis. 2006;12(2):204‐207.
14.
HerfordASBoynePJ. Ankylosis of the jaw in a patient with fibrodysplasia ossificans progressiva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96(6):680‐684.
15.
KriegbaumRKHillerupS. Fibrodysplasia ossificans progressiva (FOP): report of a case with extra-articular ankylosis of the mandible. J Craniomaxillofac Surg. 2013;41(8):856‐860.
16.
OkunoTSuzukiHInoueAKusukawaJ. Restricted mandibular movement attributed to ossification of mandibular depressors and medial pterygoid muscles in patients with fibrodysplasia ossificans progressiva: a report of 3 cases. J Oral Maxillofac Surg. 2017;75(9):1891‐1898.
17.
RamieriVBiancaCArangioPCasconeP. Myositis ossificans of the medial pterygoid muscle. J Craniofac Surg. 2010;21(4):1202‐1204.
18.
ThangaveluAVaidhyanathanANarendarR. Myositis ossificans traumatica of the medial pterygoid. Int J Oral Maxillofac Surg. 2011;40(5):545‐549.
19.
TorresAMNardisACda SilvaRASavioliC. Myositis ossificans traumatica of the medial pterygoid muscle following a third molar extraction. Int J Oral Maxillofac Surg. 2015;44(4):488‐490.
20.
KaraaliSEmekliU. Myositis ossificans traumatica of the medial pterygoid muscle after third molar tooth extraction: a case report and review of literature. J Oral Maxillofac Surg. 2018;76(11):2284.e1‐2284.e5.
